Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 CANCER IMMUNOLOGY. The "cancer immunogram".

Literature DB >> 27151852

CANCER IMMUNOLOGY. The "cancer immunogram".

Christian U Blank¹, John B Haanen², Antoni Ribas³, Ton N Schumacher⁴.

Abstract

Entities: Disease

Mesh：

Substances：
Biomarkers, Tumor

Year: 2016 PMID： 27151852 DOI： 10.1126/science.aaf2834

Source DB: PubMed Journal: Science ISSN： 0036-8075 Impact factor: 47.728

Keyword Cloud
Cited

× No keyword cloud information.

243 in total

1. Ewing sarcoma partial regression without GvHD by chondromodulin-I/HLA-A*02:01-specific allorestricted T cell receptor transgenic T cells.

Authors: Uwe Thiel; Sebastian J Schober; Ingo Einspieler; Andreas Kirschner; Melanie Thiede; David Schirmer; Katja Gall; Franziska Blaeschke; Oxana Schmidt; Susanne Jabar; Andreas Ranft; Rebeca Alba Rubío; Uta Dirksen; Thomas G P Grunewald; Poul H Sorensen; Günther H S Richter; Irene Teichert von Lüttichau; Dirk H Busch; Stefan E G Burdach
Journal: Oncoimmunology Date: 2017-04-12 Impact factor: 8.110

Review 2. PD-1 Inhibitors: Do they have a Future in the Treatment of Glioblastoma?

Authors: Mustafa Khasraw; David A Reardon; Michael Weller; John H Sampson
Journal: Clin Cancer Res Date: 2020-06-11 Impact factor: 12.531

Review 3. Tumor mutational burden in non-small cell lung cancer-the pathologist's point of view.

Authors: Frédérique Penault-Llorca; Nina Radosevic-Robin
Journal: Transl Lung Cancer Res Date: 2018-12

Review 4. The clinical utility of tumor mutational burden in non-small cell lung cancer.

Authors: Laurent Greillier; Pascale Tomasini; Fabrice Barlesi
Journal: Transl Lung Cancer Res Date: 2018-12

Review 5. Perspective on immune oncology with liquid biopsy, peripheral blood mononuclear cells, and microbiome with non-invasive biomarkers in cancer patients.

Authors: A Mitsuhashi; Y Okuma
Journal: Clin Transl Oncol Date: 2018-01-08 Impact factor: 3.405

6. Partially exhausted tumor-infiltrating lymphocytes predict response to combination immunotherapy.

Authors: Kimberly Loo; Katy K Tsai; Kelly Mahuron; Jacqueline Liu; Mariela L Pauli; Priscila M Sandoval; Adi Nosrati; James Lee; Lawrence Chen; Jimmy Hwang; Lauren S Levine; Matthew F Krummel; Alain P Algazi; Miguel Pampaloni; Michael D Alvarado; Michael D Rosenblum; Adil I Daud
Journal: JCI Insight Date: 2017-07-20

CANCER IMMUNOLOGY. The "cancer immunogram".

1. Ewing sarcoma partial regression without GvHD by chondromodulin-I/HLA-A*02:01-specific allorestricted T cell receptor transgenic T cells.

Review 2. PD-1 Inhibitors: Do they have a Future in the Treatment of Glioblastoma?

Review 3. Tumor mutational burden in non-small cell lung cancer-the pathologist's point of view.

Review 4. The clinical utility of tumor mutational burden in non-small cell lung cancer.

Review 5. Perspective on immune oncology with liquid biopsy, peripheral blood mononuclear cells, and microbiome with non-invasive biomarkers in cancer patients.

6. Partially exhausted tumor-infiltrating lymphocytes predict response to combination immunotherapy.

7. The Challenge for Development of Valuable Immuno-oncology Biomarkers.

Review 8. The tumour glyco-code as a novel immune checkpoint for immunotherapy.

Review 9. The Cancer Immunogram as a Framework for Personalized Immunotherapy in Urothelial Cancer.

10. RNA-seq for identification of therapeutically targetable determinants of immune activation in human glioblastoma.